About the accreditation program
The program will be based on TSANZ’s current Standard which is being updated and developed using the ISO 15189:2022 Standard for medical laboratories – requirements for quality and competence.
As with other NATA accreditation programs, facilities will be assessed through the NATA’s proven peer-review model, giving consumers assurance and confidence to make safe, healthy and reliable choices.
The program will contribute to better health outcomes and treatment for patients with respiratory and lung health conditions and will play a critical role in supporting health workers and researchers to prevent, cure and relieve disability caused by lung disease.
It will also allow laboratories with respiratory, sleep and blood gas services to have one management system covering all three areas, reducing duplication in the implementation and on-going maintenance of the management system.
Frequently asked questions
Why are TSANZ partnering with NATA to run a joint accreditation program?
The TSANZ Board decided to partner with NATA after an extensive review of the current Laboratory Accreditation service delivered by TSANZ. The Board believes this partnership will enable a better accreditation program for respiratory function laboratories that will deliver better health outcomes for patients. This partnership maximises NATA’s vast experience in accreditation for testing with the current TSANZ standard to be reviewed and updated in line with the international standard ISO 15189: 2022 medical laboratories – requirements for quality and competence.
Why has TSANZ signed an MoU with NATA?
The TSANZ/NATA Respiratory Function Laboratory accreditation Program will contribute to better health outcomes and treatment for patients with respiratory and lung health conditions. The Memorandum of Understanding (MoU) formalises the arrangement and sets out the responsibilities of both TSANZ and NATA in jointly administering the Program.
What is the benefit of the new TSANZ/NATA Respiratory Function Laboratory Accreditation Program?
The existing TSANZ standard will be reviewed and updated in line with the international Standard ISO 15189: 2022 Medical laboratories – requirements for quality and competence. This will allow laboratories with respiratory, sleep and blood gas services to have one management system covering all three areas, reducing duplication in the implementation and on-going maintenance of the management system.
When will the TSANZ/NATA Respiratory Function Laboratory Accreditation Program come into effect or what is the transition period?
The new TSANZ/NATA Respiratory Function Laboratory Accreditation Program is expected to come into effect by the end of 2024. Laboratories accredited under the TSANZ process will be recognised as accredited until their current TSANZ accreditation expires, or the end of 2025 (whichever period is greater).
How will the new program be established?
The joint TSANZ/NATA Respiratory Function Laboratory Accreditation Program will be established by a Steering Committee whose role will include providing technical advice, reviewing the TSANZ standard and aligning it to ISO 15189:2022, providing guidance on the scope of testing, guidance on development of technical accreditation criteria, strategic advice on industry or emerging issues and technical assessor matters.
Medical Imaging Accreditation Program (MIAP)
Sleep Disorders Services
Reference Materials Producers ( ISO 17034 ) Accreditation
Human Pathology ( ISO 15189 ) Laboratory Accreditation
Good Laboratory Practice (GLP) Accreditation
Diagnostic Imaging Accreditation Scheme (DIAS)
Testing & Calibration (ISO / IEC 17025) Accreditation
Biobanking (ISO 20387) Accreditation
Proficiency Testing Scheme Providers ( ISO / IEC 17043 ) Accreditation
Inspection ( ISO / IEC 17020 ) Accreditation